DATATRAK Challenges the Industry at Outsourcing in Clinical Trials Southeast
Calls Clinical Research Professionals to Question their eClinical Solutions
CLEVELAND, March 2, 2015 /PRNewswire/ -- DATATRAK International, Inc. (OTCQX: DTRK), a leader in developing cloud-based, unified eClinical® technologies and delivering related services for the clinical trials industry, today announced a challenge to the clinical research industry at the upcoming Outsourcing in Clinical Trials Southeast on March 24-25, 2015 in Cary, North Carolina.
"Some clinical research organizations accept solutions that limit their productivity. For DATATRAK, that's a tough one to understand. We are challenging the industry to take a moment to look at their current eClinical solutions, and ask 'Why?' Why are time consuming and repetitive manual processes acceptable? Why do we have to wait for reports across studies? Why aren't we looking for solutions to help us improve safety, data quality, and efficiency? The truth is no one should accept solutions that don't improve the research process. After all, if it isn't making the process easier, safer, or faster, it's not really doing its job," said Laurence P. Birch, Chairman and CEO, DATATRAK.
Stop by booth #21 to see how the DATATRAK ONE® Unified Experience™ simplifies eClinical for every trial. The unified eClinical® platform improves data quality, reduces risk, and lets you make informed decisions faster with our online real-time custom reporting tools, both for individual trials and across all trials on the platform.
Join DATATRAK Thought Leaders:
Tweet: Challenge your #eClinical solution to reduce risk, increase data quality, and save time at #OCTsoutheast http://bit.ly/1DGgMaC
About DATATRAK
DATATRAK International is a worldwide technology and services company delivering unified eClinical® solutions and related services for the clinical trials industry. DATATRAK built its multi-component, comprehensive solution on a single, unified platform and expanded this concept to include services delivery via DATATRAK's Clinical and Consulting Services group. The Company delivers a complete portfolio of software products designed to accelerate the reporting of clinical research data from sites to sponsors and ultimately regulatory authorities, faster and more efficiently than loosely integrated technologies. The DATATRAKONE® software solution, deployed worldwide through an ASP or Enterprise Transfer offering, supports Phase I – Phase IV drug and device studies in multiple languages throughout the world. DATATRAK has offices located in Chicago, IL Cleveland, Ohio; Bryan, Texas; and Cary (RTP), North Carolina. For more information, visit http://www.datatrak.com.
Except for the historical information contained in this press release, the statements made in this release are forward-looking statements. These forward-looking statements are made based on management's expectations, assumptions, estimates and current beliefs concerning the operations, future results and prospects of the Company and are subject to uncertainties and factors which are difficult to predict and, in many instances, are beyond the control of the Company, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. For a list of certain factors that may cause actual results to differ materially from those contemplated in these forward looking statements, please see the Company's report filed with the OTCQX Market on November 13, 2014 announcing its results for the third quarter of 2014. The Company undertakes no obligation to update publicly or revise any forward-looking statement whether as a result of new information, future events or otherwise.
SOURCE DATATRAK International, Inc.
Share this article